Related references
Note: Only part of the references are listed.The impact of low- versus high-intensity surveillance cystoscopy on surgical care and cancer outcomes in patients with high-risk non-muscle-invasive bladder cancer (NMIBC)
Michael E. Rezaee et al.
PLOS ONE (2020)
Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk score
Marie Simon et al.
PLOS ONE (2019)
Replacing surveillance cystoscopy with urinary biomarkers in followup of patients with non-muscle-invasive bladder cancer: Patients' and urologic oncologists' perspectives
Rashid K. Sayyid et al.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2018)
Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study
Siamak Daneshmand et al.
JOURNAL OF UROLOGY (2018)
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
Sam S. Chang et al.
JOURNAL OF UROLOGY (2016)
Fear of recurrence: the importance of self-efficacy and satisfaction with care in gay men with prostate cancer
Lindsey A. Torbit et al.
PSYCHO-ONCOLOGY (2015)
A Randomized Prospective Trial to Assess the Impact of Transurethral Resection in Narrow Band Imaging Modality on Non-Muscle-Invasive Bladder Cancer Recurrence
Angelo Naselli et al.
EUROPEAN UROLOGY (2012)
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder
Marko Babjuk et al.
EUROPEAN UROLOGY (2008)
Use of urinary biomarkers for bladder cancer surveillance: Patient perspectives
Ofer Yossepowitch et al.
JOURNAL OF UROLOGY (2007)
Out-of-pocket health care expenditures among older Americans with dementia
KM Langa et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2004)
The health economics of bladder cancer - A comprehensive review of the published literature
MF Botteman et al.
PHARMACOECONOMICS (2003)
Patient opinion of urinary tests versus flexible urethrocystoscopy in follow-up examination for superficial bladder cancer: A utility analysis
JLJ Vriesema et al.
UROLOGY (2000)
The use of molecular diagnostics in bladder cancer
M Han et al.
UROLOGIC ONCOLOGY (2000)
Share Paper
